- K
- KalVista Pharmaceuticals Inc.
- Kaspien Holdings Inc.
- KemPharm Inc.
- Kits Eyecare Ltd.
- Knowles Corporation
- KULR Technology Group, Inc.
- KushCo Holdings Inc.
- L
- Laird Superfood Inc.
- Lake Resources NL
- Lakeland Industries Inc.
- Landec Corporation
- Lannett Company Inc.
- Lantronix Inc.
- Lawson Products Inc.
- LeMaitre Vascular Inc.
- Lepidico Ltd.
- Lexaria Bioscience Corp.
- Life360 Inc.
- LifeMD Inc.
- LifeVantage Corporation
- Ligand Pharmaceuticals Incorporated
- Lightwave Logic Inc.
- Limbach Holdings Inc.
- Limoneira Company
- Lion Electric Inc
- LivePerson Inc.
- LiveXLive Media Inc.
- Lixte Biotechnology Holdings Inc.
- Logiq Inc.
- Loop Industries Inc.
- LSI Industries Inc.
- Luxfer Holdings PLC
- Lumos Pharma Inc.
- M
- MAG Silver Corp.
- MagnaChip Semiconductor Corporation
- MailUp S.p.A.
- Mama Mancini's Holdings Inc.
- Manitex International Inc.
- Marathon Patemt Group Inc.
- Marchex Inc.
- Marker Therapeutics Inc.
- Maxeon Solar Technologies Ltd.
- MaxLinear Inc.
- McEwen Mining Inc.
- Medallia Inc.
- Medexus Pharmaceuticals Inc.
- MediPharm Labs Corp.
- Merus N.V.
- Metamaterial Inc.
- Midwest Energy Emissions Corp.
- Mission Produce Inc.
- Mohawk Group Holdings Inc.
- Moleculin Biotech Inc.
- Monaker Group Inc.
- Monarch Casino & Resort Inc.
- Monopar Therapeutics Inc.
- Montauk Renewables Inc.
- Motorcar Parts of America Inc.
- MTBC Inc.
- Mullen Technologies Inc.
- Myomo Inc.
- N
- Nano One Materials Corp.
- Natuzzi S.p.A.
- Nautilus Inc.
- Netlist Inc.
- NewAge Inc.
- NEXE Innovations Inc.
- Northern Oil and Gas Inc.
- Nova Minerals Ltd.
- NovaBay Pharmaceuticals Inc.
- Novan Inc.
- Nuvve/Newborn Acquisition Corp.
- NV5 Global Inc.
- O
- Ocugen Inc.
- Odyssey Semiconductor Technologies
- Olema Pharmaceuticals Inc.
- Onconova Therapeutics Inc.
- One Stop Systems Inc.
- OptimizeRx Corp.
- Oragenics Inc.
- ORBCOMM Inc.
- Orion Energy Systems Inc.
- Ormat Technologies Inc.
- Orphazyme A/S
- Oryzon Genomics S.A.
- OSI Systems Inc.
- Oxurion NV
KalVista Pharmaceuticals Inc. (NASDAQ: KALV)
KalVista Pharmaceuticals Inc. (NASDAQ: KALV) is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME). KalVista is developing KVD900 as an oral on-demand therapy for acute HAE attacks, which completed a Phase 2 efficacy trial in February 2021, demonstrating statistical and clinical significance across all endpoints. KVD824 is in development for prophylactic treatment of HAE with an expected IND filing for a Phase 2 clinical trial in the first quarter of 2021. For more information, visit the company's website at www.kalvista.com
Kaspien Holdings Inc. (NASDAQ: KSPN)
Kaspien Holdings Inc. (NASDAQ: KSPN) is a leading eCommerce growth platform, offering an expanding suite of software and services to help brands grow on Amazon, Walmart, Google Shopping, Target, eBay and other online marketplaces. Founded in 2008 in Spokane, Washington, Kaspien has spent the last decade building and utilizing proprietary technologies for brand protection, marketing optimization and fulfillment efficiency to generate rapid revenue growth for Kaspien partners. Through innovative strategies and best-in-class technologies, the Spokane-based company has earned the trust of many leading brands, including 3M, Strider Bikes, ZippyPaws and others. For more information, visit the company's website at www.kaspien.com
KemPharm Inc. (NASDAQ: KMPH)
KemPharm Inc. (NASDAQ: KMPH) is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT® (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT® technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm's prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder. KemPharm's co-lead clinical development candidates for the treatment of ADHD, KP415 and KP484, are both based on a prodrug of d-methylphenidate but have differing duration/effect profiles. In addition, KemPharm has received FDA approval for APADAZ®, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen. For more information, visit the company's website at www.kempharm.com
Kits Eyecare Ltd. (TSX: KITS)
Kits Eyecare Ltd. (TSX: KITS) is a rapidly growing, digital eyecare platform providing eyewear for eyes everywhere. The company offers customers access to a vast selection of contact lenses and eyeglasses, including its own exclusive KITS designed products, as well as a robust suite of online vision tools. Kits' efficient digital platform, backed by industry-leading manufacturing and designs, removes intermediaries and enables the company to offer great prices and deliver made to order personalized products with incredible care and accuracy. Kits is creating disruption in the industry by constantly pursuing cutting-edge technologies to enable the best customer experience, including online eyewear fitting tools, virtual try-on for glasses and an integrated online vision test. For more information, visit the company's website at www.kits.com
Knowles Corp. (NYSE: KN)
Knowles Corp. (NYSE: KN) is a market leader and global provider of advanced micro-acoustic, audio processing, and precision device solutions, serving the consumer electronics, communications, medtech, defense, electric vehicle and industrial markets. Knowles uses its leading position in MEMS (micro-electro-mechanical systems) microphones and strong capabilities in audio processing technologies to optimize audio systems and improve the user experience in mobile, ear and IoT applications. Knowles is also the leader in acoustic components, high-end capacitors and mmWave RF solutions for a diverse set of markets. Founded in 1946 and headquartered in Itasca, Illinois, Knowles is a global organization with employees in over a dozen countries. The company continues to invest in high value solutions to diversify its revenue and increase exposure to high growth markets. For more information, visit the company's website at www.knowles.com
KULR Technology Group Inc. (OTCQB: KULR)
KULR Technology Group Inc. (OTCQB: KULR) develops, manufactures and licenses next-generation carbon fiber thermal management technologies for batteries and electronic systems. Leveraging the company's roots in developing breakthrough cooling solutions for NASA space missions and backed by a strong intellectual property portfolio, KULR enables leading aerospace, electronics, energy storage, 5G infrastructure and electric vehicle manufacturers to make their products cooler, lighter and safer for the consumer. For more information, visit the company's website at www.kurltechnology.com
KushCo Holdings Inc. (OTCQX: KSHB)
KushCo Holdings Inc. (OTCQX: KSHB) is a premier provider of ancillary products and services to the legal cannabis and CBD industries. KushCo Holdings' subsidiaries and brands provide product quality, exceptional customer service, compliance knowledge and a local presence in serving its diverse customer base, which consists of leading multi-state-operators (MSOs), licensed producers (LPs) and brands. Founded in 2010, KushCo Holdings has now sold more than 1 billion units to growers, brand owners, processors and producers across North America, South America and Europe, specializing in child-resistant compatible and fully customizable packaging, exclusive vape hardware and technology, and complementary solvents and natural products. For more information, visit the company's website at www.kushco.com
Laird Superfood Inc. (NYSE American: LSF)
Laird Superfood Inc. (NYSE American: LSF) creates award-winning, plant-based superfood products that are both delicious and functional. Known for its highly popular coffee creamers, hydration products, supplements, roasted and instant coffees, teas, hot chocolate and harvest snacks, the company's products are designed to enhance your daily ritual and keep consumers fueled naturally throughout the day. The company was co-founded in 2015 by the world's most prolific big-wave surfer, Laird Hamilton. Laird Superfood's offerings are environmentally conscientious, responsibly tested and made with real ingredients. For more information, visit the company's website at www.lairdsuperfood.com
Lake Resources NL (ASX: LKE) (FRA: LK1) (OTCQB: LLKKF)
Lake Resources NL (ASX: LKE) (FRA: LK1) (OTCQB: LLKKF) is a clean lithium developer utilizing cost-competitive direct extraction technology for production of sustainable, high purity lithium from its flagship Kachi Project within the Lithium Triangle in Argentina, among other projects covering 500,000 acres. This direct extraction method delivers a solution for two rising demands of electric vehicle batteries – high purity battery materials to avoid performance issues, and more sustainable, responsibly sourced materials. For more information, visit the company's website at www.lakeresources.com.au
Lakeland Industries Inc. (NASDAQ: LAKE)
Lakeland Industries Inc. (NASDAQ: LAKE) manufactures and sells a comprehensive line of industrial protective clothing and accessories for the industrial and public protective clothing market. Its products are sold globally by an in-house sales teams, a customer service group and authorized independent sales representatives to a network of over 1,600 global safety and industrial supply distributors. The company's authorized distributors supply end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical and high technology electronics manufacturers, as well as scientific, medical laboratories and the utilities industry. In addition, the company supplies federal, state and local governmental agencies and departments, such as fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control. For more information, visit the company's website at www.lakeland.com
Landec Corp. (NASDAQ: LNDC)
Landec Corp. (NASDAQ: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods Inc. and Lifecore Biomedical Inc. Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods maximizes product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. For more information, visit the company's website at www.landec.com
Lannett Co. Inc. (NYSE: LCI)
Lannett Co. Inc. (NYSE: LCI), founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at www.lannett.com
Lantronix Inc. (NASDAQ: LTRX)
Lantronix Inc. (NASDAQ: LTRX) is a global provider of engineering services, hardware, and software solutions for Edge Computing, the Internet of Things (IoT), and Out-of-Band Management (OOBM). Lantronix enables its customers to provide reliable and secure IoT Intelligent Edge and OOBM solutions while accelerating time to market. Lantronix's products and services dramatically simplify the creation, development, deployment and management of IoT projects while providing quality, reliability and security across hardware, software and solutions. With three decades of proven experience in creating robust IoT technologies and OOBM solutions, Lantronix is an innovator in enabling its customers to build new business models, leverage greater efficiencies and realize the possibilities of the Internet of Things. Lantronix is headquartered in Irvine, California. For more information, visit the company's website at www.lantronix.com
Lawson Products Inc. (NASDAQ: LAWS)
Lawson Products Inc. (NASDAQ: LAWS), headquartered in Chicago, Illinois, sells and distributes specialty products to the industrial, commercial, institutional and government maintenance, repair and operations market (MRO). The company is dedicated to helping customers in the U.S. and Canada lower their total cost of operation by increasing productivity and efficiency. The combination of Lawson Managed Inventory and the company's problem-solving professionals ensures customers always have the right parts to handle the job. Through The Bolt Supply House, customers in Western Canada have access to products at several branch locations. Under its Kent Automotive brand, the company provides collision and mechanical repair products to the automotive aftermarket. Lawson Products ships from several strategically located distribution centers to customers in all 50 states, Puerto Rico, Canada, Mexico and the Caribbean. For more information, visit the company's website at www.lawsonproducts.com
LeMaitre Vascular Inc. (NASDAQ: LMAT)
LeMaitre Vascular Inc. (NASDAQ: LMAT) is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information, visit the company's website at www.lemaitre.com
Lepidico Ltd. (OTC: LPDNF) (ASX: LPD)
Lepidico Ltd. (OTC: LPDNF) (ASX: LPD) is a global lithium exploration and development company with offices in Perth and Toronto. Differentiated by its 100% owned clean-tech L-Max® process technology that extracts lithium and recovers valuable by-products from less contested lithium-mica and phosphate minerals, Lepidico's strategic objective is to become a vertically integrated business, from mine to production of battery grade lithium chemical. In a relatively short period of time, Lepidico has established a global footprint in lithium via projects, joint ventures and alliances in Australia, Canada and Portugal. For more information, visit the company's website at www.lepidico.com
Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX)
Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company's website at www.lexariabioscience.com
Life360 Inc. (ASX: 360)
Life360 Inc. (ASX: 360) operates a platform for today's busy families, bringing them closer together by helping them better know, communicate with and protect the people they care about most. The company's core offering, the Life360 mobile app, is a market leading app for families, with features that range from communications to driving safety and location sharing. In collaboration with the PTA, Life360 offers a downloadable guide – the 'Modern Parenting Insights' Go Guide – which can be found on PTA.org. Life360 is based in San Francisco and has more than 26 million MAU located in 195 countries. Life360 is listed on the Australian Securities Exchange. For more information, visit the company's investor website investors.life360.com/investor-relations/
LifeMD Inc. (NASDAQ: LFMD)
LifeMD Inc. (NASDAQ: LFMD) is a leading telehealth company focused on direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. LifeMD's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to patients across the U.S. For more information, visit the company's website at www.lifemd.com
LifeVantage Corp. (NASDAQ: LFVN)
LifeVantage Corp. (NASDAQ: LFVN) is a pioneer in Nutrigenomics – a new science dedicated to biohacking the human aging code. The company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim(R) product line, LifeVantage(R) Omega+ and ProBio dietary supplements, the TrueScience(R) line of Nrf2 infused skin care and hair care products, Petandim(R) for Dogs, Axio(R) smart energy drink mixes and the PhysIQ(TM) weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit the company's website at www.lifevantage.com
Ligand Pharmaceuticals Inc. (NASDAQ: LGND)
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand's business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Ligand's business model is based on doing what Ligand does best: drug discovery, early-stage drug development, product reformulation and partnering. Ligand partners with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate revenue. Ligand has established multiple alliances, licenses and other business relationships with the world's leading pharmaceutical companies. For more information, visit the company's website at www.ligand.com
Lightwave Logic Inc. (OTCQX: LWLG)
Lightwave Logic Inc. (OTCQX: LWLG) is a U.S.-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform, which uses in-house proprietary high-activity and high-stability organic polymers. The company is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. For more information, visit the company's website at www.lightwavelogic.com
Limbach Holdings Inc. (NASDAQ: LMB)
Limbach Holdings Inc. (NASDAQ: LMB), with 2019 revenue of $553.3 million, is an integrated building systems solutions' firm whose expertise is the design, installation, management, service and maintenance of HVAC, mechanical, electrical, plumbing and control systems. The company primarily serves commercial and institutional clients in both new and existing facilities. Limbach's principal end-markets are healthcare, higher education, data centers, research and development, state and federal government, and general commercial. Limbach and its subsidiaries employ more than 1,500 people in 22 offices located in the Northeast, Midwest, Mid-Atlantic and Florida regions, as well as Southern California. Limbach is an industry leader in safety, advanced technology, full lifecycle solutions, human development and reliable execution. For more information, visit the company's website at www.limbachinc.com
Limoneira Co. (NASDAQ: LMNR)
Limoneira Co. (NASDAQ: LMNR), a 127-year-old international agribusiness headquartered in Santa Paula, California, has grown to become one of the premier integrated agribusinesses in the world. Limoneira is a dedicated sustainability company with 15,400 acres of rich agricultural lands, real estate properties and water rights in California, Arizona, Chile and Argentina. The company is a leading producer of lemons, avocados, oranges, specialty citrus and other crops that are enjoyed throughout the world. For more information, visit the company's website at www.limoneira.com
Lion Electric Inc. (Northern Genesis Acquisition Corp. (NYSE: NGA))
Lion Electric Inc., which intends to combine with Northern Genesis Acquisition Corp. (NYSE: NGA), is an innovative manufacturer of zero-emission vehicles. The company creates, designs and manufactures all-electric class 5 to class 8 commercial urban trucks and all-electric buses and minibuses for the school, paratransit and mass transit segments. Lion is a North American leader in electric transportation and designs, builds and assembles all its vehicles' components, including chassis, battery packs, truck cabins and bus bodies. Always actively seeking new and reliable technologies, Lion vehicles have unique features that are specifically adapted to its users and their everyday needs. For more information, visit the company's website at www.thelionelectric.com
LivePerson Inc. (NASDAQ: LPSN)
LivePerson Inc. (NASDAQ: LPSN) makes life easier for people and brands everywhere through trusted conversational AI. The company's 18,000 customers, including leading brands like HSBC, Orange, GM Financial and The Home Depot, use LivePerson's conversational solutions to orchestrate humans and AI, at scale, and create a convenient, deeply personal relationship – a conversational relationship – with their millions of consumers. LivePerson has been named to Fast Company's World's Most Innovative Companies list for its leadership in artificial intelligence. For more information, visit the company's website at www.liveperson.com
LiveXLive Media Inc. (NASDAQ: LIVX)
LiveXLive Media Inc. (NASDAQ: LIVX) is a global platform for live stream and on-demand audio, video and podcast content in music, comedy, and pop culture. LiveXLive, which has streamed over 1,200 artists in 2020, has become a go-to partner for the world's top artists and celebrity voices, as well as music festivals and concerts including Rock in Rio, EDC Las Vegas and many others. In April 2020, LiveXLive produced its first 48-hour music festival called "Music Lives" with tremendous success as it earned over 50 million views and over 5 billion views for #musiclives on TikTok on 100+ performances. LiveXLive's library of global events, video-audio podcasts and original shows are also available on Amazon, Apple TV, Roku and Samsung TVs in addition to its own app, destination site and social channels. For more information, visit the company's website at www.livexlive.com
Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT)
Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) is a clinical-stage pharmaceutical company dedicated to discovering drugs for more effective treatments for many forms of cancer and other serious common diseases. A major driver of cancer is defects in the switches that turn the biochemical pathways in cells on and off. Most cancer research over the past 30 years has focused on the "on" switches because the "off" switches, especially the master "off" switch protein phosphatase (PP2A), were believed to cause intolerable toxicity in patients. Lixte has achieved a breakthrough with its novel, first-in-class lead compound, PP2A inhibitor LB-100, by demonstrating that it is readily tolerated in cancer patients at doses associated with anti-cancer activity. The LB-100 compound, of which there are no competitors in the clinic, is currently being tested in three clinical studies with others in planning. For more information, visit the company's website at lixte.com
Logiq Inc. (OTCQX: LGIQ)
Logiq Inc. (OTCQX: LGIQ) is a U.S.-based leading global provider of eCommerce, mCommerce, and fintech business enablement solutions. Its AppLogiq™ platform-as-a-service enables small- and medium-sized businesses worldwide to easily create and deploy a native mobile app for their business without technical knowledge or background. AppLogiq empowers businesses to reach more customers, increase sales, manage logistics, and promote their products and services in an easy, affordable and highly efficient way. AppLogiq is offered in 14 languages across 10 countries and three continents, including some of the fastest-growing emerging markets in Southeast Asia. The company's subsidiary, DataLogiq, provides a data-driven, end-to-end eCommerce marketing solution for enterprises and major U.S. brands, including Home Advisor, QuinStreet and Sunrun. Its AI-powered LogiqX™ data engine delivers valuable consumer insights that enhance the ROI of online marketing spend. The company's PayLogiq™ offers mobile payments, and GoLogiq™ offers hyper-local food delivery services. For more information, visit the company's website at www.logiq.com
Loop Industries Inc. (NASDAQ: LOOP)
Loop Industries Inc. (NASDAQ: LOOP) is a technology company whose mission is to accelerate the world's shift toward sustainable PET plastic and polyester fiber and away from dependence on fossil fuels. Loop owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpets and textiles of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin and polyester fiber suitable for use in food-grade packaging, thus enabling customers to meet their sustainability objectives. Loop Industries is contributing to the global movement toward a circular economy by preventing plastic waste and recovering waste plastic for a more sustainable future for all. For more information, visit the company's website at www.loopindustries.com
LSI Industries Inc. (NASDAQ: LYTS)
LSI Industries Inc. (NASDAQ: LYTS) is a leading producer of high-performance, American-made lighting and graphic solutions. The company's strength in these applications creates opportunities for it to introduce additional solutions to its valued customers. LSI's indoor and outdoor products and services, including its digital and print graphics capabilities, are valued by architects, engineers, distributors and contractors for their quality, reliability and innovation. The company's products are used extensively in automotive dealerships, fueling stations, quick service restaurants, grocery stores and pharmacies, retail establishments, sports complexes, parking lots and garages, and commercial and industrial buildings. For more information, visit the company's website at www.lsicorp.com
Lumos Pharma Inc. (NASDAQ: LUMO)
Lumos Pharma Inc. (NASDAQ: LUMO) is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading health care investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé Ventures, and UCB. Lumos Pharma's lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, currently being evaluated in a Phase 2b clinical trial, the OraGrowtH210 Trial, for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to daily injections that current PGHD patients endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the U.S. and EU. For more information, visit the company's website at www.lumos-pharma.com
Luxfer Holdings PLC (NYSE: LXFR)
Luxfer Holdings PLC (NYSE: LXFR) is a global manufacturer of highly engineered industrial materials, which focuses on value creation by using its broad array of technical know-how and proprietary technologies. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense and emergency response, health care, transportation and general industrial applications. For more information, visit the company's website at www.luxfer.com
MAG Silver Corp. (NYSE American: MAG)
MAG Silver Corp. (NYSE American: MAG) is a Canadian exploration and development company focused on becoming a top-tier primary silver mining company, by exploring and advancing high-grade, district scale, silver-dominant projects in the Americas. Its principal focus and asset is the Juanicipio Property (44%), being developed in Joint Venture partnership with Fresnillo Plc (56%). Juanicipio is located in the Fresnillo Silver Trend in Mexico, the world's premier silver mining camp. The Joint Venture is currently constructing and developing the surface and underground infrastructure on the property to support a 4,000 tons per day mining operation. Initial underground production was achieved in Q3 2020. MAG has an expanded exploration program in place, targeting multiple highly prospective targets, both at the Juanicipio Joint Venture and at the 100% owned Deer Trail property in Utah. For more information, visit the company's website at www.magsilver.com
Magnachip Semiconductor Corp. (NYSE: MX)
Magnachip Semiconductor Corp. (NYSE: MX) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, IoT, consumer, industrial and automotive applications. The Company provides a broad range of standard products to customers worldwide. Magnachip, with more than 40 years of operating history, owns a portfolio of approximately 1,200 registered patents and pending applications, and has extensive engineering, design and manufacturing process expertise. For more information, visit the company's website at www.magnachip.com
MailUp S.p.A (BIT: MAIL)
MailUp Group (BIT: MAIL) is a vertically integrated player in the field of Cloud Marketing Technologies. Its growing suite of data-driven solutions allows SMEs and large corporations globally to master the evolving ways of communicating with customers. Starting from parent company MailUp, the group boasts a steady growth path both organically and through acquisitions: Acumbamail (Spanish and LatAm markets), Agile Telecom (wholesale SMS market) and Datatrics (artificial intelligence). The brand portfolio is completed by BEE, an email editor launched in 2017 as a complementary business line, already covering thousands of customers worldwide. Today, MailUp Group is a leading European player in the field of Cloud Marketing Technologies, serving 23,000+ customers in 100+ countries. The company is admitted to trading on the AIM Italia market managed by the Italian Stock Exchange. For more information, visit the company's website at www.mailupgroup.com
Mama Mancini's Holdings Inc. (OTCQB: MMMB)
Mama Mancini's Holdings Inc. (OTCQB: MMMB) is a marketer and distributor of specialty prepared, refrigerated and frozen all-natural Italian foods. Mama Mancini's product portfolio consists of over 20 products, including meatballs, meat loaf, chicken parmesan, sausages and pasta bowl kits, with beef, turkey, chicken and pork varieties. The company's products are sold in over 45,000 locations nationwide, including at well-known retailers such as Sam's Club, Whole Foods, Publix, Costco and Albertsons, as well as through national distributors such as Sysco and United Natural Foods. The company has a major presence on QVC, the largest direct to consumer marketer in the world. For more information, visit the company's website at www.mamamancinis.com
Manitex International Inc. (NASDAQ: MNTX)
Manitex International Inc. (NASDAQ: MNTX) is a leading worldwide provider of highly engineered mobile cranes (truck mounted straight-mast and knuckle boom cranes, industrial cranes, rough terrain cranes and railroad cranes), truck mounted aerial work platforms and specialized industrial equipment. The company's products, which are manufactured in facilities located in the U.S. and Europe, are targeted to selected niche markets where their unique designs and engineering excellence fill the needs of customers and provide a competitive advantage. Manitex has consistently added to its portfolio of branded products and equipment, both through internal development and focused acquisitions to diversify and expand the sales and profit base while remaining committed to the company's niche market strategy. Brands include Manitex, PM, Oil & Steel, Badger, MAC, PM Tadano, and Valla. For more information, visit the company's website at www.manitexinternational.com
Marathon Digital Holdings Inc. (NASDAQ: MARA)
Marathon Digital Holdings Inc. (NASDAQ: MARA) is a digital asset technology company that mines cryptocurrencies, with a focus on the blockchain ecosystem and the generation of digital assets. For more information, visit the company's website at www.marathonpg.com
Marchex Inc. (NASDAQ: MCHX)
Marchex Inc. (NASDAQ: MCHX) understands the best customers are those who call your company – they convert faster, buy more and churn less. Marchex provides solutions that help companies drive more calls, understand what happens on those calls, and convert more of those callers into customers. The company's actionable intelligence strengthens the connection between companies and their customers, bridging the physical and digital world, to help brands maximize their marketing investments and operating efficiencies to acquire the best customers. For more information, visit the company's website at www.marchex.com
Marker Therapeutics Inc. (NASDAQ: MRKR)
Marker Therapeutics Inc. (NASDAQ: MRKR) is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e., tumor targets) and kill tumor cells expressing those targets. This population of T cells is designed to attack multiple tumor targets following infusion into patients and to activate the patient's immune system to produce broad spectrum anti-tumor activity. Marker believes its portfolio of T cell therapies has a compelling product profile, as compared to current gene-modified CAR-T and TCR-based therapies. For more information, visit the company's website at www.markertherapeutics.com
Maxeon Solar Technologies Ltd. (NASDAQ: MAXN)
Maxeon Solar Technologies Ltd. (NASDAQ: MAXN) is Powering Positive Change™. Headquartered in Singapore, Maxeon designs, manufactures and sells SunPower® brand solar panels in more than 100 countries, operating the SunPower brand worldwide except in the United States and Canada. The company is a leader in solar innovation with access to over 1,000 patents and two best-in-class solar panel product lines. With operations in Africa, Asia, Oceania, Europe and Mexico, Maxeon products span the global rooftop and solar power plant markets through a network of more than 1,100 trusted partners and distributors. A pioneer in sustainable solar manufacturing, Maxeon leverages a 35-year history in the solar industry and numerous awards for its technology. For more information, visit the company's website at www.maxeon.com
MaxLinear Inc. (NYSE: MXL)
MaxLinear Inc. (NYSE: MXL) is a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multimarket applications. MaxLinear is headquartered in Carlsbad, California. For more information, visit the company's website at www.maxlinear.com
McEwen Mining Inc. (NYSE: MUX)
McEwen Mining Inc. (NYSE: MUX) is a diversified gold and silver producer and explorer focused in the Americas, with operating mines in Nevada, Canada, Mexico and Argentina. It also owns a large copper deposit in Argentina. For more information, visit the company's website at www.mcewenmining.com
Medallia Inc. (NYSE: MDLA)
Medallia Inc. (NYSE: MDLA) is the pioneer and market leader in Experience Management. Medallia's award-winning SaaS platform, the Medallia Experience Cloud, leads the market in the understanding and management of experience for customers, employees and citizens. Medallia captures experience signals created on daily journeys in person, digital and IoT interactions and applies proprietary AI technology to reveal personalized and predictive insights that can drive action with tremendous business results. Using Medallia Experience Cloud, customers can reduce churn, turn detractors into promoters and buyers, and create in-the-moment cross-sell and up-sell opportunities, providing clear and potent returns on investment. For more information, visit the company's website at www.medallia.com
Medexus Pharmaceuticals Inc. (OTCQX: MEDXF)
Medexus Pharmaceuticals Inc. (OTCQX: MEDXF) is a leading innovative and rare disease company with a strong North American commercial platform. From a foundation of proven best in class products the Company is building a highly differentiated company with a portfolio of innovative and high value orphan and rare disease products that will underpin growth for the next decade. Medexus Pharmaceuticals is focused on the therapeutic areas of auto-immune disease, hematology and allergy. The Company's leading products are: Rasuvo™ and Metoject®, a unique formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY®, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B – a hereditary bleeding disorder characterized by a deficiency of clotting factor IX in the blood, which is necessary to control bleeding; and Rupall®, an innovative prescription allergy medication with a unique mode of action. For more information, visit the company's website at www.medexus.com
MediPharm Labs Corp. (OTCQX: MEDIF)
MediPharm Labs Corp. (OTCQX: MEDIF) specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, the company formulates, consumer-tests, processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and has fully commercialized its wholly owned Australian extraction facility. MediPharm Labs Australia was established in 2017. For more information, visit the company's website at www.medipharmlabs.com
Merus N.V. (NASDAQ: MRUS)
Merus N.V. (NASDAQ: MRUS) is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For more information, visit the company's website at www.merus.nl
Metamaterial Inc. (CSE: MMAT)
delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. The company's extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, health and wellness, aerospace, automotive, and clean energy. Metamaterial's achievements have been widely recognized, including being named a Global Cleantech 100 company. For more information, visit the company's website at www.metamaterial.com
Midwest Energy Emissions Corp. (OTCQB: MEEC)
Midwest Energy Emissions Corp. (OTCQB: MEEC) is a leading environmental technologies company developing and delivering patented and proprietary solutions to the global power industry. ME2C's leading-edge services have been shown to achieve emissions removal at a significantly lower cost and with less operational impact than currently used methods, while maintaining and/or increasing power plant output and preserving the marketability of byproducts for beneficial use. For more information, visit the company's website at www.midwestemissions.com
Mission Produce Inc. (NASDAQ: AVO)
Mission Produce Inc. (NASDAQ: AVO) Mission Produce is the world's most advanced avocado network and recognized leader in the worldwide avocado business. For over 35 years Mission has been sourcing, producing and distributing fresh avocados, servicing retail, wholesale and foodservice customers in over 25 countries. The vertically integrated Company owns 11,000 acres globally and operates four state-of-the-art avocado packing facilities in key growing locations including California, Mexico and Peru and has additional sourcing capabilities in Chile, Colombia, Dominican Republic, Guatemala, New Zealand, and South Africa. Mission's global distribution network includes 11 forward distribution centers in North America, China and Europe that offer value-added services such as ripening, bagging, custom packing and logistical management. Mission is the largest global supplier of the World's Finest Avocados. For more information, visit the company's website at worldsfinestavocados.com
Mohawk Group Holdings Inc. (NASDAQ: MWK)
Mohawk Group Holdings Inc. (NASDAQ: MWK), together with its subsidiaries ("Mohawk"), is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing, and data analytics to design, develop, market and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. In addition to Healing Solutions, Mohawk has 11 owned and operated brands and sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty-related products and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods was founded today it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data and the use of social proof to validate high caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics. For more information, visit the company's website at www.mohawkgp.com
Moleculin Biotech Inc. (NASDAQ: MBRX)
Moleculin Biotech Inc. (NASDAQ: MBRX) is a clinical stage pharmaceutical company focused on the development of a broad portfolio of oncology drug candidates for the treatment of highly resistant tumors and viruses. The Company's clinical stage drugs are: Annamycin, a Next Generation Anthracycline, designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity, being studied for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as AML; WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, being studied for brain tumors, pancreatic cancer and hematologic malignancies; and WP1220, an analog to WP1066, being studied for the topical treatment of cutaneous T-cell lymphoma. Moleculin is also engaged in preclinical development of additional drug candidates, including additional Immune/Transcription Modulators, as well as compounds capable of Metabolism/Glycosylation Inhibition, such as WP1122. For more information, visit the company's website at www.moleculin.com
Monaker Group Inc. (NASDAQ: MKGI)
Monaker Group Inc. (NASDAQ: MKGI), is an innovative technology-driven company building a next-generation company through acquisition and organic growth, leveraging the strengths and channels of owned technologies with those that the company acquires, creating synergy and opportunity in the leisure space. Monaker Group is a party to a definitive agreement (subject to closing conditions, including shareholder approval for the transaction) to acquire HotPlay Enterprise Limited, an innovative in-game advertising and AdTech company. Following the completion of the proposed HotPlay acquisition, Monaker Group plans to transform into NextPlay Technologies, an innovative global technology company focused on consumer engaging products in the video gaming and travel verticals with innovative Ad Tech and Blockchain solutions. For more information, visit the company's website at www.monakergroup.com
Monarch Casino & Resort Inc. (NASDAQ: MCRI)
Monarch Casino & Resort Inc. (NASDAQ: MCRI), through its subsidiaries, owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Casino Resort Spa Black Hawk in Black Hawk, Colorado, approximately 40 miles west of Denver. For more information, visit the company's website at www.monarchcasino.com
Monopar Therapeutics Inc. (NASDAQ: MNPR)
Monopar Therapeutics (NASDAQ: MNPR) is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; and a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19. For more information, visit the company's website at www.monopartx.com
Montauk Renewables Inc. (NASDAQ: MNTK)
Montauk Renewables Inc. (NASDAQ: MNTK) is a renewable energy company specializing in the recovery and processing of biogas from non-fossil fuel sources such as dairy and landfills for beneficial use as a replacement to fossil fuels. Montauk develops, owns, and operates Renewable Natural Gas ("RNG") projects, using proven technologies that supply renewable fuel into the transportation and electrical power sectors. Having participated in the industry for over 30 years, Montauk is one of the largest U.S. producers of RNG. The company has an operating portfolio of 12 Renewable Natural Gas and three Renewable Electricity projects that span six states. For more information, visit the company's website at montaukrenewables.com
Motorcar Parts of America Inc. (NASDAQ: MPAA)
Motorcar Parts of America Inc. (NASDAQ: MPAA) is a remanufacturer, manufacturer and distributor of automotive aftermarket parts -- including alternators, starters, wheel bearings and hub assemblies, brake calipers, brake master cylinders, brake power boosters, turbochargers and diagnostic testing equipment utilized in imported and domestic passenger vehicles, light trucks and heavy-duty applications. Its products are sold to automotive retail outlets and the professional repair market throughout the United States, Canada and Mexico, with facilities located in California, New York, Mexico, Malaysia, China and India, and administrative offices located in California, Tennessee, Mexico, Singapore, Malaysia and Canada. For more information, visit the company's website at www.motorcarparts.com
MTBC Inc. (NASDAQ: MTBC)
MTBC Inc. (NASDAQ: MTBC) is a health care information technology company that provides a full suite of proprietary cloud-based solutions, together with related business services, to health care providers and hospitals throughout the United States. The company's Software-as-a-Service (or SaaS) platform includes revenue cycle management (RCM), practice management (PM), electronic health record (EHR), telehealth and patient experience management (PXM) solutions for high-performance medical groups. MTBC helps clients increase financial and operational performance, streamline clinical workflows and make better business and clinical decisions, allowing them to improve patient care while reducing administrative burdens and operating costs. For more information, visit the company's website at www.MTBC.com
Mullen Technologies Inc. (NASDAQ: NETE)
Mullen Technologies Inc. (NASDAQ: NETE), which previously announced a definitive agreement to merge with Net Element Inc., is a Southern California-based licensed vehicle manufacturer that operates in various verticals of the businesses, focusing on the automotive industry: Mullen Automotive, Mullen Energy, Mullen Auto Sales, Mullen Funding Corp. and CarHub. Each of these divisions provide Mullen with diversity of different products and services within the automotive industry. For more information, visit the company's website at www.mullenusa.com
Myomo Inc. (NYSE American: MYO)
Myomo Inc. (NYSE American: MYO) is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, visit the company's website at www.myomo.com
Nano One Materials Corp. (OTC: NNOMF)
Nano One Materials Corp. (OTC: NNOMF) has developed patented technology for the low-cost production of high-performance lithium-ion battery cathode materials used in electric vehicles, energy storage and consumer electronics. The processing technology enables lower cost feedstocks, simplifies production, and advances performance for a wide range of cathode materials. Nano One has built a demonstration pilot plant and is partnered with global leaders in the lithium-ion battery supply chain to advance its lithium iron phosphate (LFP), lithium nickel manganese cobalt oxide (NMC) and lithium nickel manganese oxide (LNM) cathode technologies for large growth opportunities in e-mobility and renewable energy storage applications. For more information, visit the company's website at www.nanoone.ca
Natuzzi S.p.A. (NYSE: NTZ)
Natuzzi S.p.A. (NYSE: NTZ) is Italy's largest furniture house and one of the most important global players in the furniture industry with an extensive manufacturing footprint and a global retail network. Natuzzi is the European lifestyle best-known brand in the upholstered furnishings sector worldwide (Brand Awareness Monitoring Report - Ipsos 2018) and has been listed on the New York Stock Exchange since May 13, 1993. Always committed to social responsibility and environmental sustainability, Natuzzi S.p.A. is ISO 9001 and 14001 certified (Quality and Environment), OHSAS 18001 certified (Safety on the Workplace) and FSC® certified (Forest Stewardship Council). For more information, visit the company's website at www.natuzzi.com
Nautilus Inc. (NYSE: NLS)
Nautilus Inc. (NYSE: NLS) is the global leader in innovative home fitness solutions. The company's diverse brand portfolio includes Bowflex®, Nautilus®, Schwinn®, and a broad selection of exercise bikes, cardio equipment, strength training products, as well as the JRNY® digital fitness platform. Nautilus Inc. empowers healthier living through individualized connected fitness experiences. The company sells its products through direct and retail channels. Nautilus Inc. uses the investor relations page of its website to make information available to its investors and the market. For more information, visit the company's website at www.nautilusinc.com
Netlist Inc. (OTCQB: NLST)
Netlist Inc. (OTCQB: NLST) provides high-performance SSDs and modular memory subsystems to enterprise customers in diverse industries. The company's NVMe™ SSD portfolio provides industry-leading performance offered in multiple capacities and form factors. HybriDIMM™, Netlist's next-generation storage class memory product, addresses the growing need for real-time analytics in Big Data applications, in-memory databases, high-performance computing and advanced data storage solutions. Netlist also manufactures a line of specialty and legacy memory products to storage customers, appliance customers, system builders and cloud and datacenter customers. Netlist holds a portfolio of patents in the areas of server memory, hybrid memory, storage class memory, rank multiplication and load reduction. For more information, visit the company's website at www.netlist.com
NewAge Inc. (NASDAQ: NBEV)
NewAge Inc. (NASDAQ: NBEV) is a purpose-driven firm intending to become the world's leading social selling and distribution company. Colorado-based NewAge commercializes a portfolio of organic and healthy products worldwide through primarily a direct route-to-market system. The company competes in three major category platforms including health and wellness, healthy appearance, and nutritional performance and leads a network of more than 400,000 exclusive independent distributors and brand partners around the world. For more information, visit the company's website at www.NewAge.com
NEXE Innovations Inc. (TSX.V: NEXE)
NEXE Innovations Inc. (TSX.V: NEXE) designs, manufactures and commercializes fully compostable, plant-based materials for everyday consumer products (currently launching single-serve beverage pods). Addressing the 50 billion+ plastic pods dumped into landfills each year, the company is targeting the USD$30B single-serve pod market (growing at 8.5% YOY), with its first commercial product, the NEXE POD, one of the only fully compostable (in as little as 35 days) plant-based solutions. Backed by five years of scientific research ($17M invested and $14M+ recent financing), NEXE Innovations is well positioned at the forefront of advanced material manufacturing and automation. For more information, visit the company's website at nexeinnovations.com
Northern Oil and Gas Inc. (NYSE American: NOG)
Northern Oil and Gas Inc. (NYSE American: NOG) is a company with a primary strategy of investing in non-operated minority working and mineral interests in oil and gas properties, with a core area of focus in the Williston Basin Bakken and Three Forks play in North Dakota and Montana. For more information, visit the company's website at www.NorthernOil.com
Nova Minerals Ltd. (OTCQB: NVAAF) (ASX: NVA) (FSE: QM3)
Nova Minerals Ltd. (OTCQB: NVAAF) (ASX: NVA) (FSE: QM3) is an exploration company focused on lithium, gold and mineral exploration in Canada, Alaska and Australia. The company plans to create shareholder value through a two-pronged strategy that includes capitalizing on the growing demand for energy storage and the resulting demand for lithium, cobalt and nickel by fast-tracking exploration and development activities at its North American assets with particular focus on its flagship lithium project and prospective Chip-Loy Nickel Cobalt Sulphides project, as well as diversification by gaining exposure to base and precious metals through the company's farm-in JV at its district scale Estelle gold copper silver project and its Northern Australian gold exploration assets. For more information, visit the company's website at www.novaminerals.com.au
NovaBay Pharmaceuticals Inc. (NYSE American: NBY)
NovaBay Pharmaceuticals Inc. (NYSE American: NBY) is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market. The company enters 2021 focused on growing sales of its high-quality, differentiated consumer products: Avenova®, the premier antimicrobial lid and lash spray, and CelleRx® Clinical Reset, a breakthrough product that marked the company's entry into a new beauty category late last year. NovaBay aims to expand consumer access to both products to brick-and-mortar retail stores in the months to come. For more information, visit the company's website at www.novabay.com
Novan Inc. (NASDAQ: NOVN)
Novan Inc. (NASDAQ: NOVN) is a clinical development-stage biotechnology company focused on leveraging its proprietary nitric oxide (NO) based technology platform, NITRICIL™, to generate macromolecular New Chemical Entities (NCEs) to treat multiple indications in dermatology, men's and women's health, infectious diseases and gastroenterology conditions with significant unmet needs. The company's lead product candidate, SB206, a topical antiviral gel for the treatment of molluscum contagiosum, is currently being evaluated in the B-SIMPLE4 pivotal Phase 3 clinical study. The company believes that SB206 as a topical, at-home, caregiver-applied therapy with a rapid treatment benefit, if approved, would address an important patientcare need for the treatment of molluscum. For more information, visit the company's website at www.novan.com
Nuvve/Newborn Acquisition Corp. (NASDAQ: NBAC)
Nuvve/Newborn Acquisition Corp. (NASDAQ: NBAC) is a special purpose acquisition company with a definitive agreement to merge with Nuvve Corp. Nuvve is a San Diego-based green energy technology company whose mission is to lower the cost of electric vehicle ownership while supporting the integration of renewable energy sources, including solar and wind. The company's proprietary vehicle-to-grid (V2G) technology – Nuvve's Grid Integrated Vehicle (GIVe™) platform – is refueling the next generation of electric vehicle fleets through cutting-edge, bidirectional charging solutions. Since its founding in 2010, Nuvve has been responsible for successful V2G projects on five continents and is deploying commercial services worldwide. For more information, visit the company's website at www.nuvve.com
NV5 Global Inc. (NASDAQ: NVEE)
NV5 Global Inc. (NASDAQ: NVEE) is a leading provider of compliance, technology and engineering consulting solutions for public and private sector clients supporting infrastructure, utility, and building assets and systems. The Company primarily focuses on six business verticals: testing, inspection and consulting, infrastructure support services, utility services, buildings and program management, environmental health sciences and geospatial technology services. NV5 operates out of more than 100 offices nationwide and abroad. For more information, visit the company's website at www.NV5.com
Ocugen Inc. (NASDAQ: OCGN)
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Ocugen's breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – "one to many" and the company's novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. For more information, visit the company's website at www.ocugen.com
Odyssey Semiconductor Technologies Inc. (OTCQB: ODII)
Odyssey Semiconductor Technologies Inc. (OTCQB: ODII) is developing disruptive proprietary technology that will allow for gallium nitride (GaN) to replace silicon carbide (SiC) as the leading high voltage power switching semiconductor material. Based in Ithaca, New York, the Company operates a 10,000-square-foot semiconductor wafer manufacturing facility complete with a mix of class 1,000 and class 10,000 clean space as well as tools for advanced semiconductor development and production. Odyssey Semiconductor also offers a world-class semiconductor device development and foundry service, filling the gap between university labs and large-scale wafer foundries. For more information, visit the company's website at www.odysseysemi.com
Olema Pharmaceuticals Inc. (NASDAQ: OLMA)
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women's cancers. Olema's lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer. Olema is headquartered in San Francisco. For more information, visit the company's website at www.olema.com
Onconova Therapeutics Inc. (NASDAQ: ONTX)
Onconova Therapeutics Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor, ON 123300, is planned to begin a dose-escalation and expansion Phase 1 trial in the U.S. in the first half of 2021, and a dose-escalation and expansion Phase 1 trial is currently underway in China. Onconova's product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. For more information, visit the company's website at www.onconova.com
One Stop Systems Inc. (NASDAQ: OSS)
One Stop Systems Inc. (NASDAQ: OSS) designs and manufactures innovative specialized high-performance computing modules and systems, including customized servers, compute accelerators, expansion systems, flash storage arrays and Ion Accelerator storage software. These products are used for deep learning, AI, defense, finance and entertainment applications, and empower scientists, engineers, creators and other professionals to push the boundaries of their industries. OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe storage to build award-winning systems, including many industry firsts, for OEMs and government customers. The company enables AI on the Fly® by bringing AI datacenter performance to 'the edge' and on mobile platforms, and by addressing the entire AI workflow, from high-speed data acquisition to deep learning, training and inference. OSS products are available directly or through global distributors. For more information, visit the company's website at www.onestopsystems.com
OptimizeRx Corp. (NASDAQ: OPRX)
OptimizeRx Corp. (NASDAQ: OPRX) is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of health care providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care to retail pharmacy, through mobile patient engagement. For more information, visit the company's website at www.optimizerx.com
Oragenics Inc. (NYSE: OGEN)
Oragenics Inc. (NYSE: OGEN) is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. The company has established two exclusive worldwide channel collaborations with Intrexon Corporation and its subsidiaries. The collaborations allow Oragenics to accelerate the development of much-needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat and esophagus. For more information, visit the company's website at www.oragenics.com
ORBCOMM Inc. (NASDAQ: ORBC)
ORBCOMM Inc. (NASDAQ: ORBC) is a global leader and innovator in the industrial Internet of Things, providing solutions that connect businesses to their assets to deliver increased visibility and operational efficiency. The company offers a broad set of asset monitoring and control solutions, including seamless satellite and cellular connectivity, unique hardware and powerful applications, all backed by end-to-end customer support, from installation to deployment to customer care. ORBCOMM has a diverse customer base including premier OEMs, solutions customers and channel partners spanning transportation, supply chain, warehousing and inventory, heavy equipment, maritime, natural resources and government. For more information, visit the company's website at www.orbcomm.com
Orion Energy Systems Inc. (NASDAQ: OESX)
Orion Energy Systems Inc. (NASDAQ: OESX) enables business to digitize and reduce their carbon footprints by providing innovative LED lighting systems and turnkey project implementation, including installation and commissioning of fixtures, controls and IoT systems; ongoing system maintenance; and program management. Orion systems utilize patented design elements to deliver industry-leading energy efficiency, enhanced optical and thermal performance and ease of installation, providing long-term financial, environmental and work-space benefits to a diverse customer base, including nearly 40% of the Fortune 500. For more information, visit the company's website at www.orionlighting.com
Ormat Technologies Inc. (NYSE: ORA)
Ormat Technologies Inc. (NYSE: ORA) is a leading geothermal company and the only vertically integrated company engaged in geothermal and recovered energy generation ("REG"), with robust plan to accelerate long-term growth in the storage segment to establish leading position in the U.S. energy storage market.. Ormat owns, operates, designs, manufactures and sells geothermal and REG power plants primarily based on the Ormat Energy Converter – a power generation unit that converts low-, medium- and high-temperature heat into electricity. The Company has engineered, manufactured and constructed power plants, which it currently owns or has installed to utilities and developers worldwide, totaling approximately 3,200 MW of gross capacity. Ormat leveraged its core capabilities in the geothermal and REG industries and its global presence to expand the Company activity into the energy storage services, solar Photovoltaic (PV) and energy storage plus Solar PV. Ormat's current 932 MW of geothermal and Solar generating portfolio is spread globally in the U.S., Kenya, Guatemala, Indonesia, Honduras, and Guadeloupe and its 73 MW energy storage portfolio is located in the U.S.
Orphazyme A/S (NASDAQ: ORPH)
Orphazyme A/S (NASDAQ: ORPH) is a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases. The company is harnessing amplification of Heat-Shock Proteins (or HSPs) in order to develop and commercialize novel therapeutics for diseases caused by protein misfolding, protein aggregation, and lysosomal dysfunction, including lysosomal storage diseases and neuromuscular degenerative diseases. Arimoclomol, the company's lead candidate, is in clinical development for four orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), sporadic Inclusion Body Myositis (sIBM) and Gaucher disease. Orphazyme is headquartered in Denmark and has operations in the U.S. and Switzerland. For more information, visit the company's website at www.orphazyme.com
Oryzon Genomics S.A. (OTC: ORYZF)
Oryzon Genomics S.A. (OTC: ORYZF) is a clinical stage biopharmaceutical company considered as the European champion in Epigenetics. Oryzon has one of the strongest portfolios in the field. Oryzon's LSD1 program has rendered two compounds, vafidemstat and iadademstat, in Phase II clinical trials. In addition, Oryzon has ongoing programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurological diseases. Oryzon has offices in Spain and the United States. Oryzon is one of the most liquid biotech stocks in Europe with +90 million shares negotiated in 2020. The company had a +25% stock performance in 2020 and its cash runway is expected to extend till 1Q2023. For more information, visit the company's website at www.oryzon.com
OSI Systems Inc. (NASDAQ: OSIS)
OSI Systems Inc. (NASDAQ: OSIS) is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, health care, defense and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information, visit the company's website at www.osi-systems.com
Oxurion NV (OTC: TBGNF)
Oxurion NV (OTC: TBGNF) is a biopharmaceutical company developing next-generation standard ophthalmic therapies. These improve preservation of vision in patients with diabetic eye disease, the world's leading cause of blindness in people of working age. Oxurion's clinical development pipeline comprises two potential new standards of care for DME patients: THR-149, a plasma kallikrein inhibitor for DME-patients who previously respond poorly to anti-VEGF therapy; and THR-687, a pan-RGD integrin antagonist for all DME patients. Oxurion developed Jetrea® (ocriplasmin), the only pharmacological vitreolysis drug approved for treating symptomatic vitreomacular adhesion (in the U.S.) and vitreomacular traction (outside the U.S.). In March 2020, Oxurion and Inceptua Group signed a global commercial license agreement for Jetrea®. Oxurion is headquartered in Leuven, Belgium. For more information, visit the company's website at www.oxurion.com